SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : MMGRD combo of synetic/medical manger
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Olds who wrote (4)8/16/1999 6:35:00 PM
From: Michael Olds   of 13
 
Medical Manager
Merrill Lynch stock report as of 8/4
Fundamentals on Track Buy
Long Term Buy
12 Month Price Objective $140

Investment Highlights:
 There have been no new fundamental developments to account for the recent weakness of the stock following last month's merger of Synetic and Medical Manager. Our fiscal 1999 and fiscal 2000 estimates remain unchanged.
 The synergies provided by both Medical Manager and its 72.1% owned subsidiary CareInsite remain a key variable in the rapid rollout of CareInsite's healthcare connectivity channel in the Greater New York area this year.
 We estimate that the number of high prescribing physicians identified for initial deployment next month is rapidly approaching 1000. This appears consistent with our expectations.
 We believe that CareInsite continues to generate a high degree of interest among managed care payers both in the Greater New York area and elsewhere. Concentration of covered lives should encourage a rapid uptake of physician transaction activity.
 Medical Manager's stock appears to be significantly undervalued based on the components of its business. Its share of CareInsite's valuation is about $40 per share. The implied value for Medical Manager's physician office and Plastics business is only 18x their estimated net income contributionor about .6x projected growth. Our price objective for Medical manager is based on our $65 price target for CareInsite's stock and a higher valuation for its other businesses.
 Stock valuation should continue to be influenced by the performance of CareInsite stock which could stay volatile. We note that Medical Manager's public stock float is significantly greater than CareInsite.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News